logo
  

Stock Alert: Fulgent Genetics Gains 18% On Launching At-home Covid-19 Test

Shares of Fulgent Genetics, Inc. (FLGT) climbed $3 or 18.18% Tuesday after-hours after the genetic testing services company said it launched an at-home testing solution for Covid-19, after receiving Emergency Use Authorization (EUA) from the FDA.

Fulgent Genetics plans to offer the testing service from next week through Picture Genetics, the company's consumer-initiated genetic testing platform.

"Since launching our RT-PCR Test (non-at-home test) several months ago, we have won several strategic accounts and are processing thousands of tests daily with an average turnaround time of 24 hours from receipt of sample. This at-home COVID-19 test will diversify our go-to-market approach for tests by utilizing our existing consumer-initiated genetic testing platform," commented Brandon Perthuis, Chief Commercial Officer at Fulgent Genetics.

In the last quarter, Fulgent had reported revenue growth of 44% year-over-year at $7.8 million.

"In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand," said Ming Hsieh, Chairman and Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT